Dapagliflozin
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5186 publications
Circadian reprogramming of inflammation and metabolism in chronic kidney disease.
Journal: Renal failure
Published: September 07, 2026
Primary Care Recognition of Rabson-Mendenhall Syndrome Despite Absence of Classical Diabetic Symptoms.
Journal: The American journal of case reports
Published: September 05, 2026
Effective Protection Against Alcohol-Related Cardiac Damage: Dapagliflozin.
Journal: Journal of cardiovascular pharmacology
Published: September 04, 2026
Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.
Journal: Diabetes technology & therapeutics
Published: September 04, 2026
Pharmacotherapy of heart failure: Impact of the 2021 guideline update on guideline-directed medical therapy assessed using a Japanese employee health insurance claims database.
Journal: International journal of clinical pharmacology and therapeutics
Published: September 03, 2026
Protective effect of Dapagliflozin on hepatic encephalopathy induced by thioacetamide in rats: involvement of ERK, JNK, and Nrf2/HO-1 pathways.
Journal: Toxicology mechanisms and methods
Published: August 27, 2026
Expression of Concern: Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 27, 2026
Response surface methodology-optimized microwell spectrophotometric method for saxagliptin quantitation: a sustainable, high-throughput approach for pharmaceutical quality control.
Journal: Analytical methods : advancing methods and applications
Published: August 20, 2026
Integrative Transcriptomics Links Dapagliflozin-Opposed Macrophage Programs to BHLHE40-Associated Regulation and NFKB1-Associated Signaling in HFpEF.
Journal: Omics : a journal of integrative biology
Published: August 17, 2026
Corrigendum to "Randomized Controlled Trial of Dapagliflozin for Post-Transplant Diabetes Mellitus in Renal Transplant Recipients" [Kidney International Reports Volume 11, Issue 7, July 2026, 106559].
Journal: Kidney international reports
Published: August 11, 2026
Mesenchymal stem cell-derived microvesicles versus sodium glucose cotransporter-2 inhibitors in ameliorating acute renal cortical injury of ischemia reperfusion rat model.
Journal: Ultrastructural pathology
Published: August 07, 2026
Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 06, 2026
Last Updated: 09/26/2026